The 2nd generation basal insulins demonstrate some key benefits over the first generation, in terms of lower risk of hypoglycemia and less variability in diabetic patients. These characteristics significantly help physicians overcome the patient's fear of early use of insulin. In this video, Dr. Alice Cheng shares some key evidence to differentiate the two 2nd generation basal insulins on different parameters like the risk of hypoglycemia, glycemic variability and more. Watch the video to know more.